| scholarly article | Q13442814 |
| P50 | author | Garima Pandey | Q91280449 |
| P2093 | author name string | Manoj Kumar | |
| Punit Kaur | |||
| Shyam S Chauhan | |||
| Sameer Bakhshi | |||
| Bhaskar Thakur | |||
| Prerna Jain | |||
| P2860 | cites work | Structure of human dCK suggests strategies to improve anticancer and antiviral therapy | Q24305246 |
| Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds | Q27667908 | ||
| Binding of DNA-Intercalating Agents to Oxidized and Reduced Quinone Reductase 2 | Q27703093 | ||
| Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis | Q28259436 | ||
| Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients | Q28273494 | ||
| Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression | Q28299475 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion | Q33612349 | ||
| Retracted: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas | Q33742019 | ||
| Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models. | Q33920338 | ||
| Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells | Q34057949 | ||
| Cathepsin B: a potential prognostic marker for inflammatory breast cancer | Q34499322 | ||
| Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 | ||
| Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose | Q35019204 | ||
| Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia | Q36053792 | ||
| RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. | Q36074431 | ||
| Targeting Cathepsin B for Cancer Therapies | Q36326605 | ||
| Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients | Q36619772 | ||
| Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential | Q37161711 | ||
| Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma | Q37327749 | ||
| Cathepsin B as a cancer target | Q38072054 | ||
| Cathepsin B: multiple roles in cancer | Q38200056 | ||
| Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth | Q39234393 | ||
| Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group | Q44158544 | ||
| Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients | Q44219922 | ||
| Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors | Q48249993 | ||
| Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells | Q48822168 | ||
| Prognostic significance of cathepsin L expression in pediatric acute myeloid leukemia | Q49976007 | ||
| Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy. | Q50959078 | ||
| Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. | Q52725969 | ||
| Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators | Q73483295 | ||
| Cathepsin inhibition induces apoptotic death in human leukemia and lymphoma cells | Q73850003 | ||
| Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice | Q80883582 | ||
| Cathepsins B and L in peripheral blood mononuclear cells of pediatric acute myeloid leukemia: potential poor prognostic markers | Q84453238 | ||
| P433 | issue | 12 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| childhood acute myeloid leukemia | Q55779816 | ||
| P304 | page(s) | 2634-2649 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | American Journal of Cancer Research | Q17511667 |
| P1476 | title | Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia | |
| P478 | volume | 9 |
Search more.